CB2

CB2 is primarily expressed in the immune cells and tissues of the body. Like CB1, CB2 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently lowers cAMP upon activation. This, in turn, regulates many second messenger pathways.

CBDA

CBDA is a precursor of CBD (obtained by decarboxylation of CBDA) that has physiological and therapeutic properties of its own right.

Cancer

Cancer treatment is one of the main therapeutic applications of cannabinoids. Research has identified cannabinoids with excellent analgesic properties, cannabinoids that increase appetite and cannabinoids that reduce nausea.

Prostate Cancer

Prostate cancer is the development of cancer in the prostate.

Cervical cancer

Cervical Cancer is a type of cancer that develops from the cervix.

Bone cancer

Bone cancers result from primary tumor invasion to bone. cannabinoids can be used to relieve Bone Cancer pain through their anti-inflammatory properties and also they could be used to treat cancer itself.

Leukemia

Leukemia cancers usually begin in the bone marrow and involves abnormal white blood cell production.

Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for cannabinoid therapy.

Breast cancer

Breast cancers develop from breast tissue. cannabinoids have anti Breast Cancer properties involving inhibition of cancer growth and metastasis.